Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients. Takahashi T, Shigeyasu K, Kondo Y, Takeda S, et al. BMC Cancer 2025;25:1.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Takahashi T, Shigeyasu K, Kondo Y, Takeda S, et al. Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients. BMC Cancer 2025;25:1.
PMID: 39748254